BIO — Bio Rad Laboratories Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapSuper Stock

Annual income statement for Bio Rad Laboratories, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	R2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	2,923	2,802	2,671	2,567	2,583
Cost of Revenue
Gross Profit	1,663	1,568	1,431	1,379	1,344
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Total Operating Expenses	2,423	2,330	2,333	2,298	2,542
Operating Profit	500	472	338	269	41.2
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	5,449	-4,704	-850	-2,343	996
Provision for Income Taxes
Net Income After Taxes	4,254	-3,628	-637	-1,844	760
Net Income Before Extraordinary Items
Net Income	4,254	-3,628	-637	-1,844	760
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	4,254	-3,628	-637	-1,844	760
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	143	-121	-21.2	-64.3	34.1